Viraj Aero Raises $4.5M for Steam Injection Tech

ArcSpace

There is no economic growth without proper infrastructure. Therefore, we believe that Space infrastructure must be disrupted to enable Space to become the next trillion-dollar industry. ArcSpace designs and manufactures complex spacecraft payloads that benefit from in-space structural assembly, and manages in-space assembly operations through its proprietary technology.

Valerio Therapeutics

At Valerio Therapeutics, we are pioneering a new generation of precision therapies to tackle complex and underserved diseases. Our proprietary V-Body platform is based on two fully synthetic single-domain antibody (sdAb) libraries, derived from a human VH and a fully humanized VHH. Engineered for optimal performance, this ultra-small sdAb platform (~15 kDa) surpasses the limitations of current treatments by enabling deep tissue penetration and highly precise therapeutic delivery, ensuring superior efficacy and target engagement. Our approach integrates innovative target identification using advanced predictive models, antibody engineering and optimization for high specificity and affinity, and drug conjugate development leveraging cutting-edge linker and payload technologies. We focus on rapidly transitioning from preclinical research to clinical proof of concept in indications with high unmet medical needs. Committed to translating breakthrough science into tangible medical solutions, we advance our therapeutic candidates to key development milestones before forging strategic partnerships. Through co-development, out-licensing, and R&D collaborations, we maximize the potential of our innovations to bring life-changing treatments to patients worldwide.

Ingenico

Ingenico is the global leader in payment acceptance and services. We support our customers, and their customers to do more with payments. Active in 32 countries, with over 3,000 employees we have been at the forefront of the commerce landscape for over four decades. With tens of millions of payment devices deployed worldwide, powered by over 2,500 apps, the company is servicing the needs of millions of consumers every day. Through our advanced integrated solutions and network of partnerships, we simplify the world of payments and bring value added services to move commerce forward.

Innate Pharma

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca. Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.